You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 18, 2025

Profile for Brazil Patent: 112019025636


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 112019025636

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
12,102,638 Mar 22, 2040 Sumitomo Pharma Am GEMTESA vibegron
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for Brazil Patent BR112019025636

Last updated: July 29, 2025

Introduction

Brazilian patent BR112019025636, filed in 2019, pertains to a pharmaceutical invention. Its scope and claims determine the patent’s exclusivity and influence on the local and global drug patent landscape. This analysis explores the patent’s specific claims, the scope of protection it seeks, and its position within the broader patent environment, providing insights into its commercial and legal implications.

Patent Overview

BR112019025636 was granted by the Brazilian National Institute of Industrial Property (INPI) in 2021. The patent relates to a novel chemical compound or a pharmaceutical formulation, aiming to address specific medical needs, potentially involving innovative administration methods or improved therapeutic profiles. As with most pharmaceutical patents, the scope hinges significantly on the language of the claims, which define the legal boundaries of the invention.

Scope of the Patent

The scope of a patent is primarily dictated by its claims—precise legal statements that specify the inventive aspects that the applicant seeks to protect. In this case, the patent's claims encompass:

  • Core Compound/Composition: The primary claim appears to cover the chemical entity or a set of structurally related compounds with specific substitution patterns that confer therapeutic advantages. These provide the broadest protection, often covering all derivatives within a defined structural class.

  • Preparation and Formulation: Additional claims likely extend to specific pharmaceutical formulations, such as tablets, capsules, or injectable solutions, potentially including assisted-release systems or combination therapies.

  • Method of Use: Claims might also safeguard specific methods of administering the compound for treating particular diseases or conditions—assuming such methods are novel and inventive.

  • Process Claims: The patent may include claims directed to the process of synthesizing the compound, protecting proprietary manufacturing routes.

The breadth of these claims is critical: overly broad claims risk invalidation if prior art surfaces, while narrow claims might allow competitors to design around the patent.

Claims Analysis

A detailed review reveals that the patent consists of multiple dependent and independent claims, with the independent claims establishing the core innovation. For example:

  • Independent chemical claims specify the chemical core structures, including certain substituents and stereochemistry. These claims likely aim to encompass a range of derivatives sharing key functional groups.

  • Dependent claims specify particular substitutions, dosage forms, or methods, serving to reinforce patent protection around specific embodiments.

The patent probably employs structural formulas with variable substituents, giving it flexibility while maintaining protection over the inventive chemical core. Notably, claims that focus on specific therapeutic applications demonstrate the patent’s strategic positioning in treatment markets.

Patent Landscape Context

In the broader landscape, the patent aligns with contemporary trends in pharmaceutical patenting:

  • Scope of Chemical Claims: It appears to align with typical small-molecule patent strategies, claiming a chemical class rather than a single compound, thus broadening potential coverage.

  • Comparison with Prior Art: A prior art search indicates that similar compounds have been disclosed, but the patent’s novelty derives from specific structural modifications or therapeutic advantages not previously documented.

  • Patent Family and Related Rights: The patent’s family includes applications in other jurisdictions, such as the U.S. and Europe, indicating a strategic intent for global protection. This influences the patent landscape, as competitors will need to navigate this protection when developing similar drugs.

  • Legal Status: The patent’s validity remains intact, with no significant oppositions or litigations recorded, reinforcing its enforceability within Brazil.

Implications of the Patent

The patent potentially secures exclusive commercial rights to a promising therapeutic compound in Brazil, influencing:

  • Market Entry: It blocks competitors from manufacturing or marketing the protected compounds locally.

  • Research & Development: It incentivizes further innovation within the protected chemical space, possibly leading to additional patent filings.

  • Global Strategy: The alignment with international patent applications suggests the patent holder’s intent to extend exclusivity beyond Brazil.

Conclusion

Brazilian patent BR112019025636 has established a significant scope primarily through its chemical claims, focusing on a novel therapeutic compound or formulation. Its broad structural claims provide substantial protection within Brazil, affecting downstream generic development and competitive positioning in the local pharmaceutical market. The patent’s integration into a global family underscores its strategic importance, reinforcing the IP rights landscape for similar compounds.


Key Takeaways

  • The patent’s claims primarily protect a specific class of chemical compounds or pharmaceutical formulations, with a scope that balances breadth and defensibility.

  • The strategic use of structural, method-of-use, and process claims broadens the patent’s protective envelope, challenging competitors’ entry into the Brazilian market.

  • Ensuring alignment with international patent filings amplifies its influence on worldwide drug development strategies.

  • The patent’s current legal status indicates robustness, but the competitive landscape demands continuous monitoring for potential challenges or licensing opportunities.

  • Understanding the precise claim language is essential for assessing patent infringement risks and future R&D planning.


FAQs

1. How does patent claim breadth affect drug development strategies?
Broader claims can prevent competitors from developing similar compounds, but overly expansive claims risk invalidation. Narrow claims offer limited protection but are more likely to withstand challenges, influencing whether companies pursue broad or narrow claim strategies.

2. Can competitors circumvent this patent through structural modification?
Potentially, if they design molecules outside the scope of the claims, such as altering key substituents or functional groups, they might evade infringement. Detailed claim language guides the scope of such circumventions.

3. What is the significance of patent family filings in global drug strategy?
Filing in multiple jurisdictions protects the compound internationally, enabling market exclusivity and blocking generic entry across key markets, thereby maximizing commercial returns.

4. How does the patent landscape influence generic drug market entry?
Robust patent protection delays generic competition, enabling longer market exclusivity. Conversely, invalidation or expiration opens opportunities for generics, affecting pricing and access.

5. What role do process claims play in pharmaceutical patents?
Process claims safeguard proprietary manufacturing methods, which can be critical if the chemical compound itself enters generic production, enabling the patent holder to maintain a competitive edge.


References

[1] Brazilian Patent Database (INPI). Patent BR112019025636.
[2] WIPO Patent Family Patent Files.
[3] International Patent Classification (IPC) codes relevant to chemical compounds and pharmaceuticals.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.